These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17239022)

  • 1. Hilar lymph nodes sampling at the time of liver transplantation for hepatocellular carcinoma: to do or not to do? Meta-analysis to determine the impact of hilar lymph nodes metastases on tumor recurrence and survival in patients with hepatocellular carcinoma undergoing liver transplantation.
    Sotiropoulos GC; Malagó M; Molmenti EP; Lösch C; Lang H; Frilling A; Broelsch CE; Neuhäuser M
    Transpl Int; 2007 Feb; 20(2):141-6. PubMed ID: 17239022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases.
    Sotiropoulos GC; Molmenti EP; Lösch C; Beckebaum S; Broelsch CE; Lang H
    Eur J Med Res; 2007 Oct; 12(10):527-34. PubMed ID: 18024261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases.
    Bennett JJ; Schmidt CR; Klimstra DS; Grobmyer SR; Ishill NM; D'Angelica M; DeMatteo RP; Fong Y; Blumgart LH; Jarnagin WR
    Ann Surg Oncol; 2008 Apr; 15(4):1130-6. PubMed ID: 18228106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL; Zang YJ; Chen XG; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
    Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
    Mas VR; Fisher RA; Archer KJ; Yanek KC; Williams B; Dumur CI; Maluf DG
    Transplantation; 2007 Apr; 83(7):973-81. PubMed ID: 17460570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.
    Marelli L; Grasso A; Pleguezuelo M; Martines H; Stigliano R; Dhillon AP; Patch D; Davidson BR; Sharma D; Rolles K; Burroughs AK
    Ann Surg Oncol; 2008 Dec; 15(12):3503-11. PubMed ID: 18777193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria].
    Fan J; Zhou J; Xu Y; Qiu SJ; Wu ZQ; Yu Y; Huang XW; Tang ZY; Wang YQ
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1227-31. PubMed ID: 16796876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthotopic liver transplantation in hepatocellular carcinoma: comparison of results in incidental and known hepatocellular carcinoma.
    Toufeeq Khan TF; Reddy KS; Johnston TD; Ranjan D
    Int Surg; 2006; 91(4):185-7. PubMed ID: 16967677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with recurrent hepatocellular carcinoma in liver transplantation.
    Park JW; Lee KW; Kim SJ; Choi SH; Heo JS; Kwon CH; Kim DJ; Han YS; Lee SK; Joh JW
    Transplant Proc; 2006 Sep; 38(7):2121-2. PubMed ID: 16980018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time.
    Yoo HY; Patt CH; Geschwind JF; Thuluvath PJ
    J Clin Oncol; 2003 Dec; 21(23):4329-35. PubMed ID: 14581446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
    Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Hara Y; Waguri N; Suda T; Aoyagi Y; Hatakeyama K
    Transplant Proc; 2006 Dec; 38(10):3636-9. PubMed ID: 17175353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of hepatocellular carcinoma: is the jury still out?
    Morris-Stiff G; Gomez D; de Liguori Carino N; Prasad KR
    Surg Oncol; 2009 Dec; 18(4):298-321. PubMed ID: 19062271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for hepatocellular carcinoma: single nodule with Child-Pugh class A sized less than 3 cm.
    Moon DB; Lee SG; Hwang S
    Dig Dis; 2007; 25(4):320-8. PubMed ID: 17960067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F; Angele MK; Rentsch M; Graeb C; Gerbes A; Löhrs U; Beuers U; Jauch KW
    Clin Transplant; 2007; 21(6):696-701. PubMed ID: 17988261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
    Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
    Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
    Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcome.
    Courdi A; Largillier R; Ferrero JM; Lallement M; Raoust I; Ettore F; Peyrottes I; Chamorey E; Balu-Maestro C; Chapellier C
    Oncology; 2006; 71(5-6):361-8. PubMed ID: 17785993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.